Reaction Details Report a problem with these data
Target
Alpha-2C adrenergic receptor
Ligand
BDBM30993
Substrate
n/a
Ki
1.71±n/a nM
Comments
PDSP_1589
Citation
 Bylund, DB; Blaxall, HS; Iversen, LJ; Caron, MG; Lefkowitz, RJ; Lomasney, JW Pharmacological characteristics of alpha 2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning. Mol Pharmacol 42:1-5 (1992) [PubMed] 
Target
Name:
Alpha-2C adrenergic receptor
Synonyms:
ADRA2C | adrenergic Alpha2C
Type:
Enzyme Catalytic Domain
Mol. Mass.:
27257.01
Organism:
OK
Description:
adrenergic Alpha2C ADRA2C OK::G3GWB4
Residue:
230
Sequence:
MAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSFYRRSDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQLPEPLFKFFFWIGYCKSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ
  
Inhibitor
Name:
BDBM30993
Synonyms:
Ajmalicine | MLS000111555 | Raubasine | SMR000107477 | cid_251561
Type:
Small organic molecule
Emp. Form.:
C21H24N2O3
Mol. Mass.:
352.4269
SMILES:
COC(=O)C1=COC(C)C2CN3CCc4c([nH]c5ccccc45)C3CC12 |t:4|
Structure:
Search PDB for entries with ligand similarity: